Thursday
May 18
2017

India’s drugmakers need more time to meet international standards: industry group

India’s big drugmakers will need at least five more years to improve their manufacturing standards and data reliability to a level demanded by international regulators, said a senior industry official.

The lengthy timeline is a concern not only in India but around the world, as India’s pharmaceutical firms supply a third of the drugs sold in the United States and a large percentage in other countries.

U.S. and European Union regulators have called on India’s $16 billion pharmaceutical industry to step up their efforts if it wants to continue to dominate the generic drugs sector.

Source: Reuters (link opens in a new window)

Categories
Health Care
Tags
drugs, generic drugs, health care, India, pharmaceutical industry